Paragonix's donor heart transport system wins FDA nod

02/12/2013 | American City Business Journals

The FDA has given Paragonix Technologies 510(k) clearance for its Sherpa Pak Cardiac Transport System to be used in preserving donor hearts in transit for as long as four hours. The device uses oxygenated perfusion and cold storage technology, and the company hopes it will eventually be cleared to keep donor hearts alive for up to 12 hours.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI